CXCL2 (alias Gro2) shows elevated expression in colorectal cancer already in premalignant lesions and in CRC [42] and it could accelerate tumor cell growth by inducing cell proliferation in a mouse implantation model [43]. Here, CXCL2 is linked to colorectal cancer.